BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,138 filers reported holding BAXTER INTL INC in Q4 2019. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $608,000 | +98.7% | 7,554 | +98.4% | 0.50% | +228.8% |
Q2 2021 | $306,000 | -60.1% | 3,807 | -60.1% | 0.15% | -42.9% |
Q4 2020 | $767,000 | -58.9% | 9,553 | -58.9% | 0.27% | -68.5% |
Q3 2020 | $1,868,000 | +51.1% | 23,223 | +61.8% | 0.85% | -8.3% |
Q2 2020 | $1,236,000 | +131.0% | 14,355 | +117.9% | 0.93% | +14.6% |
Q1 2020 | $535,000 | -64.6% | 6,587 | -63.5% | 0.81% | +42.2% |
Q4 2019 | $1,510,000 | +5.3% | 18,063 | +10.2% | 0.57% | +4.0% |
Q3 2019 | $1,434,000 | -99.9% | 16,391 | -29.7% | 0.55% | -8.2% |
Q2 2019 | $1,909,826,000 | -8.3% | 23,319 | -9.0% | 0.60% | -15.1% |
Q1 2019 | $2,083,731,000 | +104979.7% | 25,627 | -15.0% | 0.70% | -60.8% |
Q4 2018 | $1,983,000 | -14.6% | 30,134 | 0.0% | 1.79% | +55.9% |
Q3 2018 | $2,323,000 | +10.6% | 30,134 | +6.0% | 1.15% | +9.5% |
Q2 2018 | $2,100,000 | +21.0% | 28,436 | +6.5% | 1.05% | +3.3% |
Q1 2018 | $1,736,000 | – | 26,688 | – | 1.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |